Neuropeptide Y receptors: a promising target for cancer imaging and therapy

Volume: 2, Issue: 3, Pages: 215 - 219
Published: Aug 12, 2015
Abstract
Neuropeptide Y (NPY) was first identified from porcine brain in 1982, and plays its biological functions in humans through NPY receptors (Y1, Y2, Y4 and Y5). NPY receptors are known to mediate various physiological functions and involve in a majority of human diseases, such as obesity, hypertension, epilepsy and metabolic disorders. Recently, NPY receptors have been found to be overexpressed in many cancers, so they emerged as promising target...
Paper Details
Title
Neuropeptide Y receptors: a promising target for cancer imaging and therapy
Published Date
Aug 12, 2015
Volume
2
Issue
3
Pages
215 - 219
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.